Tag Archives: FDA

I spoke at the FDA Tobacco Products Scientific Advisory Committee meeting held yesterday (June 26, 2024) to consider Philip Morris International’s (PMI) Modified Risk Tobacco Product (MRTP) application to renew authorization to make modified (read “reduced”) risk claims about its Swedish Match General Snus.  I expected the meeting to end with TPSAC voting on aContinue reading “Shocking FDA TPSAC Meeting on PMI General Snus modified risk application”